product summary
company name :
Hycult Biotech
product type :
antibody
product name :
CD34, Mouse, mAb MEC14.7
catalog :
HM1015
quantity :
100 µg
clonality :
monoclonal
host :
rat
conjugate :
nonconjugated
clone name :
MEC14.7
reactivity :
human, mouse
application :
western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation, flow cytometry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section
more info or order :
Hycult Biotech product webpage
citations: 38
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry - paraffin section; human; 1:20; fig 5b
Destouches D, Sader M, Terry S, Marchand C, Maillé P, Soyeux P, et al. Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer. Oncotarget. 2016;7:69397-69411 pubmed publisher
  • immunohistochemistry - paraffin section; mouse; 1:50
Sogawa C, Wakizaka H, Aung W, Jin Z, Tsuji A, Furukawa T, et al. C-type natriuretic peptide specifically acts on the pylorus and large intestine in mouse gastrointestinal tract. Am J Pathol. 2013;182:172-9 pubmed publisher
  • immunohistochemistry; mouse
Navis A, Hamans B, Claes A, Heerschap A, Jeuken J, Wesseling P, et al. Effects of targeting the VEGF and PDGF pathways in diffuse orthotopic glioma models. J Pathol. 2011;223:626-34 pubmed publisher
Kokki E, Karttunen T, Olsson V, Kinnunen K, Yla Herttuala S. Human Vascular Endothelial Growth Factor A165 Expression Induces the Mouse Model of Neovascular Age-Related Macular Degeneration. Genes (Basel). 2018;9: pubmed publisher
Kizuka Shibuya F, Tokuda N, Takagi K, Adachi Y, Lee L, Tamura I, et al. Locally existing endothelial cells and pericytes in ovarian stroma, but not bone marrow-derived vascular progenitor cells, play a central role in neovascularization during follicular development in mice. J Ovarian Res. 2014;7:10 pubmed publisher
Rønø B, Engelholm L, Lund L, Hald A. Gender affects skin wound healing in plasminogen deficient mice. PLoS ONE. 2013;8:e59942 pubmed publisher
Navis A, Bourgonje A, Wesseling P, Wright A, Hendriks W, Verrijp K, et al. Effects of dual targeting of tumor cells and stroma in human glioblastoma xenografts with a tyrosine kinase inhibitor against c-MET and VEGFR2. PLoS ONE. 2013;8:e58262 pubmed publisher
Kizuka F, Tokuda N, Takagi K, Adachi Y, Lee L, Tamura I, et al. Involvement of bone marrow-derived vascular progenitor cells in neovascularization during formation of the corpus luteum in mice. Biol Reprod. 2012;87:55 pubmed publisher
Vanacker J, Luyckx V, Dolmans M, des Rieux A, Jaeger J, Van Langendonckt A, et al. Transplantation of an alginate-matrigel matrix containing isolated ovarian cells: first step in developing a biodegradable scaffold to transplant isolated preantral follicles and ovarian cells. Biomaterials. 2012;33:6079-85 pubmed publisher
Kröger C, Vijayaraj P, Reuter U, Windoffer R, Simmons D, Heukamp L, et al. Placental vasculogenesis is regulated by keratin-mediated hyperoxia in murine decidual tissues. Am J Pathol. 2011;178:1578-90 pubmed publisher
Dath C, Dethy A, van Langendonckt A, Van Eyck A, Amorim C, Luyckx V, et al. Endothelial cells are essential for ovarian stromal tissue restructuring after xenotransplantation of isolated ovarian stromal cells. Hum Reprod. 2011;26:1431-9 pubmed publisher
Horiguchi A, Kuroda K, Sato A, Asakuma J, Ito K, Hayakawa M, et al. STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma. Br J Cancer. 2010;102:1592-9 pubmed publisher
Marsaud V, Tchakarska G, Andrieux G, Liu J, Dembele D, Jost B, et al. Cyclin K and cyclin D1b are oncogenic in myeloma cells. Mol Cancer. 2010;9:103 pubmed publisher
Sagara Y, Miyata Y, Nomata K, Hayashi T, Kanetake H. Green tea polyphenol suppresses tumor invasion and angiogenesis in N-butyl-(-4-hydroxybutyl) nitrosamine-induced bladder cancer. Cancer Epidemiol. 2010;34:350-4 pubmed publisher
Mordant P, Loriot Y, Leteur C, Calderaro J, Bourhis J, Wislez M, et al. Dependence on phosphoinositide 3-kinase and RAS-RAF pathways drive the activity of RAF265, a novel RAF/VEGFR2 inhibitor, and RAD001 (Everolimus) in combination. Mol Cancer Ther. 2010;9:358-68 pubmed publisher
Ito S, Natsume A, Shimato S, Ohno M, Kato T, Chansakul P, et al. Human neural stem cells transduced with IFN-beta and cytosine deaminase genes intensify bystander effect in experimental glioma. Cancer Gene Ther. 2010;17:299-306 pubmed publisher
Kats Ugurlu G, Roodink I, de Weijert M, Tiemessen D, Maass C, Verrijp K, et al. Circulating tumour tissue fragments in patients with pulmonary metastasis of clear cell renal cell carcinoma. J Pathol. 2009;219:287-93 pubmed publisher
Yanagisawa M, Fujimoto Ouchi K, Yorozu K, Yamashita Y, Mori K. Antitumor activity of bevacizumab in combination with capecitabine and oxaliplatin in human colorectal cancer xenograft models. Oncol Rep. 2009;22:241-7 pubmed
Fan T, Yuan W, Cong R, Yang X, Wang W, Jing Z. [Studies on the purification of water-soluble holothurian glycosides from Apostichopus japonicus and their tumor suppressing activity]. Yao Xue Xue Bao. 2009;44:25-31 pubmed
Van Eyck A, Jordan B, Gallez B, Heilier J, Van Langendonckt A, Donnez J. Electron paramagnetic resonance as a tool to evaluate human ovarian tissue reoxygenation after xenografting. Fertil Steril. 2009;92:374-81 pubmed publisher
Shinoda Y, Ogata N, Higashikawa A, Manabe I, Shindo T, Yamada T, et al. Kruppel-like factor 5 causes cartilage degradation through transactivation of matrix metalloproteinase 9. J Biol Chem. 2008;283:24682-9 pubmed publisher
Magnon C, Opolon P, Connault E, Mir L, Perricaudet M, Martel Renoir D. Canstatin gene electrotransfer combined with radiotherapy: preclinical trials for cancer treatment. Gene Ther. 2008;15:1436-45 pubmed publisher
Claes A, Schuuring J, Boots Sprenger S, Hendriks Cornelissen S, Dekkers M, van der Kogel A, et al. Phenotypic and genotypic characterization of orthotopic human glioma models and its relevance for the study of anti-glioma therapy. Brain Pathol. 2008;18:423-33 pubmed publisher
Claes A, Wesseling P, Jeuken J, Maass C, Heerschap A, Leenders W. Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization. Mol Cancer Ther. 2008;7:71-8 pubmed publisher
Claes A, Gambarota G, Hamans B, van Tellingen O, Wesseling P, Maass C, et al. Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment. Int J Cancer. 2008;122:1981-6 pubmed
Koponen J, Kekarainen T, E Heinonen S, Laitinen A, Nystedt J, Laine J, et al. Umbilical cord blood-derived progenitor cells enhance muscle regeneration in mouse hindlimb ischemia model. Mol Ther. 2007;15:2172-7 pubmed
Yamamura H, Hirano N, Koyama H, Nishizawa Y, Takahashi K. Loss of smooth muscle calponin results in impaired blood vessel maturation in the tumor-host microenvironment. Cancer Sci. 2007;98:757-63 pubmed
Miyagi M, Aoyagi K, Kato S, Shirouzu K. The TIMP-1 gene transferred through adenovirus mediation shows a suppressive effect on peritoneal metastases from gastric cancer. Int J Clin Oncol. 2007;12:17-24 pubmed
Leppänen P, Kholova I, Mähönen A, Airenne K, Koota S, Mansukoski H, et al. Short and long-term effects of hVEGF-A(165) in Cre-activated transgenic mice. PLoS ONE. 2006;1:e13 pubmed
Galaup A, Cazes A, Le Jan S, Philippe J, Connault E, Le Coz E, et al. Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc Natl Acad Sci U S A. 2006;103:18721-6 pubmed
Renoir J, Stella B, Ameller T, Connault E, Opolon P, Marsaud V. Improved anti-tumoral capacity of mixed and pure anti-oestrogens in breast cancer cell xenografts after their administration by entrapment in colloidal nanosystems. J Steroid Biochem Mol Biol. 2006;102:114-27 pubmed
Nozawa H, Tadakuma T, Ono T, Sato M, Hiroi S, Masumoto K, et al. Small interfering RNA targeting epidermal growth factor receptor enhances chemosensitivity to cisplatin, 5-fluorouracil and docetaxel in head and neck squamous cell carcinoma. Cancer Sci. 2006;97:1115-24 pubmed
Tanaka T, Furukawa T, Fujieda S, Kasamatsu S, Yonekura Y, Fujibayashi Y. Double-tracer autoradiography with Cu-ATSM/FDG and immunohistochemical interpretation in four different mouse implanted tumor models. Nucl Med Biol. 2006;33:743-50 pubmed
Maillard S, Gauduchon J, Marsaud V, Gouilleux F, Connault E, Opolon P, et al. Improved antitumoral properties of pure antiestrogen RU 58668-loaded liposomes in multiple myeloma. J Steroid Biochem Mol Biol. 2006;100:67-78 pubmed
Fiedler U, Christian S, Koidl S, Kerjaschki D, Emmett M, Bates D, et al. The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors. Am J Pathol. 2006;168:1045-53 pubmed
Leppänen P, Koota S, Kholova I, Koponen J, Fieber C, Eriksson U, et al. Gene transfers of vascular endothelial growth factor-A, vascular endothelial growth factor-B, vascular endothelial growth factor-C, and vascular endothelial growth factor-D have no effects on atherosclerosis in hypercholesterolemic low-density lipopr. Circulation. 2005;112:1347-52 pubmed
Kimura Y, Sumiyoshi M. Antitumor and antimetastatic actions of eicosapentaenoic acid ethylester and its by-products formed during accelerated stability testing. Cancer Sci. 2005;96:441-50 pubmed
Ishii G, Sangai T, Sugiyama K, Ito T, Hasebe T, Endoh Y, et al. In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions. Stem Cells. 2005;23:699-706 pubmed
product information
Catalog no :
HM1015
Title :
CD34, Mouse, mAb MEC14.7
Clone no :
MEC14.7
Quantity :
100 µg
Application code :
flow cytometry,frozen sections,immunofluorescence,immunoprecipitation,paraffin sections,western blot
Species :
mouse
Host species :
rat
Isotype :
IgG2a
Conjugate :
purified
Type :
mAb
Antigen :
CD34
Meta data :
stem cells, progenitor, hematopoietic
more info or order :
Hycult Biotech product webpage
company information
Hycult Biotech
Frontstraat 2a
5405 PB UDEN
support@hycultbiotech.com
http://www.hycultbiotech.com
31 0 413 25 13 35
headquarters: Netherlands
Hycult Biotech develops, produces and markets antibodies, antibody based products and more specifically immunoassays for innate immunity and directly related fields, with an emphasis on complement, neutrophil proteins, TLR, scavenger receptors and acute phase proteins. Furthermore, we have a strong interest in progressing research in the area of inflammation and cell damage caused by pathogens or oxidation factors.

Hycult Biotech’s mission and strategy is to advance insight in innate immunity related diseases, for the benefit of individuals and their quality of life.

As a leader within focused fields of immunology and cell biology, we develop products for the life sciences and in accordance with our mission it is our ambition to facilitate the transition of these products from research use into diagnostic testing. Many of our reagents are developed in close cooperation with scientists worldwide. Hycult Biotech has built a strong network with over 40 close scientific collaborations with leading international research institutes. We contribute to numerous projects and as a result, can continuously offer early access to an expanding range of innovative reagents. Hycult Biotech has been ISO-9001 certified since 1998 and we upgraded our certification to ISO-13485 in 2007, with a milestone of our first release of CE marked assays in 2009. Our vision, knowledgeable team and quality management system guarantee products of the highest grade combined with excellent technical service.